Pursuant to Regulation 30 of Listing Regulation, please find enclosed Press Release - \Prestigious Medical and Public Health Journal \ The Lancet Regional Health\ Publishes Pivotal Phase 3 Clinical Study on Miqnaf (Nafithromycin)- A Landmark for India's Antibiotic Innovation\.